Table 3 Factors associated with being asked to take part in a clinical trial as the outcome
From: Access to clinical trials among oncology patients: results of a cross sectional survey
Predictor | Comparison | OR (95% CI) | Type 3 p-value |
|---|---|---|---|
Centre | B vs A | 2.90 (1.27, 6.61) | 0.0386 |
C vs A | 1.93 (0.93, 4.01) | ||
Private Health Insurance | Yes vs No | 0.73 (0.41, 1.29) | 0.2759 |
Time Since Diagnosis | 13 to 24 months vs 12 months or less | 0.24 (0.11, 0.53) | 0.0010 |
Over 24 months vs 12 months or less | 0.46 (0.25, 0.87) | ||
Chemotherapy treatment | Yes vs No | 0.65 (0.34, 1.24) | 0.1873 |
Biological treatment | Yes vs No | 0.61 (0.27, 1.37) | 0.2295 |
Remission | Not in remission vs In remission | 0.60 (0.30, 1.22) | 0.2321 |
Do not know vs In remission | 0.52 (0.23, 1.21) |